Kaarina Kowalec
Anknuten till Forskning
E-postadress: kaarina.kowalec@ki.se
Besöksadress: Nobels väg 12a, 17165 Solna
Postadress: C8 Medicinsk epidemiologi och biostatistik, C8 MEB I Lu Projektgrupp, 171 77 Stockholm
Artiklar
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(6):1393-1404
- Article: NEUROLOGY. 2024;102(5):e209135
- Article: PHARMACOGENOMICS. 2024;25(4):175-186
- Article: HEALTH SCIENCE REPORTS. 2024;7(1):e1844
- Article: AMERICAN JOURNAL OF PSYCHIATRY. 2023;180(10):714-722
- Article: TRANSLATIONAL PSYCHIATRY. 2023;13(1):301
- Article: JOURNAL OF PSYCHOSOMATIC RESEARCH. 2023;172:111415
- Article: NEUROLOGY. 2023;101(5):E522-E532
- Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2023;43(4):313-319
- Journal article: BMJ OPEN. 2023;13(6):e073782
- Article: THE LANCET REGIONAL HEALTH. EUROPE. 2023;29:100621
- Article: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023;45(1):233-239
- Article: BMJ PAEDIATRICS OPEN. 2023;7(1):e001686
- Article: FRONTIERS IN PSYCHIATRY. 2023;14:1260420
- Article: NEUROLOGY: NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2023;10(1):e200062
- Article: AMERICAN JOURNAL OF PSYCHIATRY. 2022;179(11):844-852
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e31-e32
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e270
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e198
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e32-e33
- Article: GENERAL HOSPITAL PSYCHIATRY. 2022;77:21-28
- Article: BMC RESEARCH NOTES. 2022;15(1):162
- Article: MOLECULAR PSYCHIATRY. 2022;27(5):2439-2447
- Article: MOLECULAR PSYCHIATRY. 2022;27(3):1667-1675
- Article: JAMA PSYCHIATRY. 2022;79(3):260-269
- Article: PLOS ONE. 2022;17(11):e0278072
- Article: FRONTIERS IN PHARMACOLOGY. 2022;13:871136
- Article: FRONTIERS IN PHARMACOLOGY. 2022;13:886652
- Article: ACR OPEN RHEUMATOLOGY. 2021;3(12):889-896
- Article: MULTIPLE SCLEROSIS JOURNAL. 2021;27(13):2077-2084
- Article: MOLECULAR PSYCHIATRY. 2021;26(8):4487-4495
- Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):163
- Article: ELIFE. 2021;10:e58430
- Article: INFLAMMATORY BOWEL DISEASES. 2021;27(1):58-64
- Article: NEUROLOGY. 2020;95(5):e446-e456
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:s236
- Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):157
- Article: NATURE GENETICS. 2018;50(8):1081-1085
- Article: NEUROLOGY. 2018;90(4):e332-e341
- Article: NEUROLOGY. 2017;89(24):2455-2461
- Journal article: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2017;88:173
- Journal article: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2017;88:167
- Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2016;85(3):328-333
- Article: NATURE GENETICS. 2015;47(9):1079-1084
- Article: JOURNAL OF VIRAL HEPATITIS. 2013;20(2):122-130
- Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2013;2(1):57-59
- Article: JOURNAL OF MEDICAL VIROLOGY. 2012;84(9):1369-1375
- Article: JOURNAL OF MEDICAL VIROLOGY. 2010;82(6):942-948
- Visa fler
Alla övriga publikationer
- Preprint: MEDRXIV. 2023
- Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1197195
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E159
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E50
- Review: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2022;111(4):919-930
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(1_SUPPL):52
- Conference publication: BIRTH DEFECTS RESEARCH. 2022;114(9):395
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):212
- Review: PSYCHOLOGICAL MEDICINE. 2021;51(13):2168-2177
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;51:E137-E138
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;51:E237
- Preprint: MEDRXIV. 2021
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(1_SUPPL):58-59
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S184
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S85-S86
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S215
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:648
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1099-1100
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1332-1333
- Editorial comment: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2017;12:1-3
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:991
- Review: EXPERT OPINION ON DRUG SAFETY. 2014;13(10):1305-1317
- Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2013;2(3):183-192
- Visa fler
Forskningsbidrag
- Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in CanadaCanadian Institutes of Health Research1 January 2023 - 31 December 2023
- Precision Genomics SuiteCanada Foundation for Innovation22 November 2022
- Psychiatric Disorder Genomic Risk Scores as a Correlate of Disease Activity and Progression in Multiple SclerosisCongressionally Directed Medical Research Programs15 July 2020 - 14 July 2024
- Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queriesCanadian Institutes of Health Research1 September 2019 - 31 August 2022
- Identifying Clinical, Demographic, & Genomic Risk Factors for Treatment-Resistant Psychiatric DisordersCanadian Institutes of Health Research1 April 2018 - 3 January 2019
- The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) ProgramCanadian Institutes of Health Research1 November 2015 - 28 February 2022
- Genotype specific approaches to beta-interferon therapy in Multiple SclerosisCanadian Institutes of Health Research1 May 2011 - 31 October 2014
Anställningar
- Assistant Professor, Genetics, University of Manitoba, 2019-
- Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-2025
Examina och utbildning
- PhD, Genetics and epidemiology, University of British Columbia, 2016
- MSc, Viral genetics, University of Manitoba, 2011
- BSc, Microbiology, University of Manitoba, 2008